Regular ArticleAllelic Loss on Chromosome Arm 8p: Analysis of Sporadic Epithelial Ovarian Tumors
References (27)
- et al.
Loss of heterozygosity in human ovarian cancer on chromosome 19q
Gynecol Oncol
(1997) - et al.
Cancer statistics
CA Cancer J Clin
(1998) - et al.
BRCA1 mutations in primary breast and ovarian cancers
Science
(1994) - et al.
BRCA2 mutations in primary breast and ovarian cancers
Nat Genet
(1996) - et al.
Overexpression and mutation of p53 in epithelial ovarian cancer
Cancer Research
(1991) - et al.
Mutation of the NM23 gene, loss of hetetozygosity at the NM23 locus and K-ras mutation in ovarian carcinoma: correlation with tumor progression and NM23 gene expression
Br J Cancer
(1995) - et al.
NM23 and tumour metastasis: basic and translational advances
Biochem Soc Symp
(1998) - et al.
Distinction of low grade from high grade human ovarian carcinomas on the basis of loss of heterozygosity on chromosomes 3, 6, and 11 and Her-2/neu gene amplification
Cancer Res
(1991) - et al.
Identification of a 1300 kilobase deletion unit on chromosome 7q31.3 in invasive epithelial ovarian carcinomas
Oncogene
(1997) - et al.
Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer
Genes Chromosomes Cancer
(1996)
Allelic loss on chromosome 8p in BRCA1 mutation positive breast/ovarian cancers
Breast J
Polymerase chain allelotyping of human ovarian cancer
Br J Cancer
Human epithelial cancer allelotype
Cancer Res
Cited by (50)
DUSP26 negatively affects the proliferation of epithelial cells, an effect not mediated by dephosphorylation of MAPKs
2010, Biochimica et Biophysica Acta - Molecular Cell ResearchPDLIM2 suppresses human T-cell leukemia virus type I Tax-mediated tumorigenesis by targeting Tax into the nuclear matrix for proteasomal degradation
2009, BloodCitation Excerpt :Currently, the mechanism by which PDLIM2 gene is suppressed in cancer cells is unknown. One clue is the genomic location of PDLIM2, 8p21, which frequently undergoes allelic loss in ovarian and prostate cancers.47,48 Another possibility is epigenetic suppression of PDLIM2, as PDLIM4, a family member of PDLIM2 that shows tumor suppression function, is repressed by DNA methylation in many cancers.49
RhoBTB2 (DBC2) is a mitotic E2F1 target gene with a novel role in apoptosis
2008, Journal of Biological ChemistryCharacterization of CSOC 882, a novel immortalized ovarian cancer cell line expressing EGFR, HER2, and activated AKT
2007, Gynecologic OncologyCitation Excerpt :CSOC 882 cells also possess a deletion of 8p21. Deletions of 8p21 have been observed previously and are associated with increased malignant potential [15]. We find it of considerable interest that the 4EBP1 gene is located at 8p21.
Mutation and expression analysis of LZTS1 in ovarian cancer
2006, Cancer Letters
- 1
To whom correspondence and reprint requests should be addressed at National Cancer Institute, Building 10, Room 2A33, 10 Center Drive, MDC 1500, Bethesda, MD 20892-1500. Fax: (301) 480-5142.